eFFECTOR Therapeutics Inc. (NASDAQ: EFTR)
$0.19
+0.1090 ( +135.40% ) 1.6M
eFFECTOR Therapeutics Inc is a clinical-stage biopharmaceutical company focused on pioneering the development of a new class of oncology drugs referred to as selective translation regulator inhibitors (STRIs).
Market Data
Open
$0.19
Previous close
$0.08
Volume
1.6M
Market cap
$0.61M
Day range
$0.13 - $0.26
52 week range
$0.03 - $20.61
SEC Fillings
| Form Type | Description | Pages | Date |
|---|---|---|---|
| 8-k | 8K-related | 14 | May 20, 2024 |
| 8-k | 8K-related | 14 | May 17, 2024 |
| 4 | Insider transactions | 1 | May 17, 2024 |
| 4 | Insider transactions | 1 | May 17, 2024 |
| 8-k/a | 8K-related | 15 | May 09, 2024 |
| 8-k | 8K-related | 15 | May 09, 2024 |
| 10-q | Quarterly Reports | 73 | May 09, 2024 |
| 8-k | 8K-related | 16 | May 09, 2024 |
| ars | Annual reports | 1 | Apr 26, 2024 |
| def | Proxies and info statements | 13 | Apr 26, 2024 |